A promising new strategy for “reactivating” genes that cause cancer tumors to shrink and die has now been developed. The discovery may aid the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs.